Society of Hematologic Oncology Sixth Annual Meeting
Avatar

Next Questions in Myeloma: Biology, Smoldering Myeloma, High-risk, MRD, and How to Salvage Therapy

By Society of Hematologic Oncology Sixth Annual Meeting FEATURING Sundar Jagannath
10/2018
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
08:14
2018 Pan Pacific Lymphoma Conference

Evolution of Myeloma Induction Regimens

Feat. S. Holstein
15:01
Krina Patel

Clinical Trials in Myeloma in 2018

19:48
Gareth J Morgan

Contemporary Design of MM Treatment: Developing New Therapeutic Endpoint...

17:02
Ajai Chari

Diagnosing Smoldering Multiple Myeloma

09:49
Nina Shah

Maximizing the Initial Gains in Myeloma Therapy: Consolidation and Maint...

21:39
Natalie Callander

Smoldering Myeloma: Risk Stratification and Therapeutic Options

25:50
The University of Kansas Cancer Center

MM - Overview of Trials Presented at ASH 2018

Feat. A. Abdallah
13:25
Shaji Kumar

Evolving Concepts in the Diagnosis and Risk Stratification of Myeloma

15:36
Society of Hematologic Oncology Sixth Annual Meeting

How Does Genetics and MRD Impact Myeloma Treatment Or Doesn’t It?

Feat. A. Nooka
19:40
Peter Voorhees

Approach to the Patient with Refractory & Multiple Relapsed Multiple Mye...

17:02
Thomas Martin

Novel Clinical Trials for Smoldering Multiple Myeloma in 2018

15:46
Society of Hematologic Oncology Sixth Annual Meeting

Myeloma State of the Art Update: Bone Disease, MRD Assessment, How to Ma...

Feat. S. Lonial
12:31
Indy Hematology Review

What's New in Immunotherapy and Genomics in Multiple Myeloma?

Feat. K. Anderson
15:10
Ajay Nooka

Early Relapse: Choosing Among Different Second Line Regimens in Myeloma

15:30
Parameswaran Hari

Refractory and Relapsing Myeloma - When to Treat and Options Available

16:27
Dana-Farber Cancer Institute

Is it Time to Treat Patients with Smoldering Myeloma in 2018?

Feat. I. Ghobrial
12:43
Bart Barlogie

Clinical Manifestations & Diagnostic Work Up of Myeloma

17:57
City of Hope

Should Everyone Receive Monoclonal Antibodies at First Myeloma Relapse? No!

Feat. J. Mikhael
06:22
Parameswaran Hari

Treating Refractory & Relapsing Myeloma: Current Trends and Recommendati...

17:16
Society of Hematologic Oncology Sixth Annual Meeting

Emerging Data on Management and Imaging of Myeloma Bone Disease

Feat. M. Dimopoulos